Darwin Global Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
VPM
VCM
BBA
Darwin Global Management's INSM Position: Q1 2026 in Review
Darwin Global Management reduced its Insmed (INSM) stake by 20% in Q1 2026, selling an estimated $635M and leaving 16,805,184 shares worth $2.58B. The position accounts for 68.33% of the portfolio, ranked #1.
Darwin Global Management first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.64B in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Darwin Global Management held 16,805,184 shares of Insmed worth $2.58B as of Q1 2026.
- Darwin Global Management sold 4,128,093 Insmed shares in Q1 2026, an estimated $635M.
- Insmed made up 68.33% of Darwin Global Management's portfolio in Q1 2026, its #1 holding.
- Darwin Global Management first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
- Darwin Global Management's Insmed position peaked at $3.64B in Q4 2025.
- 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Darwin Global Management's 13F filing for Q1 2026, filed 15 May 2026.